Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
taxon 5207Also known as: Blastomyces neoformans, Cryptococcus neoformans var. grubii, Debaryomyces neoformans, Filobasidiella neoformans, Filobasidiella neoformans Kwon-Chung, 1976, Lipomyces neoformans, Saccharomyces neoformans, Torula neoformans, Torulopsis neoformans
No local or indigenous names recorded yet.
Not yet assessed
Occurrence records: Recorded mostly outside Africa. 245 of 4,400 GBIF records (6%) are from Africa (checked 10/12/2026). A hint from GBIF and the genomes on this Hub, not an assessment: GBIF includes zoo and travel records.
Species that share this one's nearest groups in NCBI Taxonomy. This is how they're classified, not a phylogeny. See it in the species tree.
Origin: hub
1 download
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCA_010065285.1 · View at source ↗
Collection: Botswana
Sequencing: Oxford Nanopore MinION · Canu v. 1.5 · 78x coverage
Released: 2020-02-10 · Submitted by: Broad Institute
publiccc0AFDSI-SEQ-5942 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: BW · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 0.02 Gb · scaffold N50 216,930 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
33 downloads
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCA_056622355.1 · View at source ↗
Download annotation (GFF3) · Download CDS (FASTA) · Download proteins (FASTA)
Collection: Botswana: Francistown
Sequencing: Oxford Nanopore MinION; Illumina HiSeq · Canu v. 2.2 · 83x coverage
Released: 2026-04-07 · Submitted by: Duke University
publiccc0AFDSI-SEQ-6170 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: BW · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 0.02 Gb · scaffold N50 216,930 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
1 download
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCA_010233705.1 · View at source ↗
Collection: South Africa
Sequencing: Oxford Nanopore MiniION · Canu v. 1.5 · 167x coverage
Released: 2020-02-06 · Submitted by: Broad Institute
publiccc0AFDSI-SEQ-6171 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: ZA · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 0.02 Gb · scaffold N50 216,930 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 11/8/2026 · Last updated: 11/8/2026
Source: NCBI AB204868.1 · View at source ↗
Released: 2012-04-04
publiccc0AFDSI-SEQ-6527 Country of origin not recorded: see how benefit-sharing works →Publicly accessible — no request needed.
No AlphaFold DB proteome found for this species.
PRIDE — project-level reference (metadata only; no per-protein identifications are available via PRIDE's public API)
Fungal extracellular vesicles are recoverable across variable ultracentrifugation speeds but display species-specific profiles of sedimentation (PXD076414) ↗AFDSI-PROJREF-651
Effects of human immunoglobulins on Cryptococcus neoformans morphology and proteome (PXD072710) ↗AFDSI-PROJREF-652
Quantitative DIA/SWATH proteomic profiling of SAGA complex mutants in Cryptococcus neoformans (PXD071194) ↗AFDSI-PROJREF-653
Cellular and molecular responses of Cryptococcus to brilacidin (MMV1634402) and KIN1400 (MMV019724) (PXD070309) ↗AFDSI-PROJREF-654
TurboID-Cna1 in cryptococcus using high resolution mass spectrometry, Yadav and Heitman (PXD067478) ↗AFDSI-PROJREF-655
THE CELL WALL INTEGRITY PATHWAY KINASE MPK1 REGULATES EXTRACELLULAR VESICLE BIOGENESIS AND APOPTOTIC-LIKE VESICLE PRODUCTION IN CRYPTOCOCCUS NEOFORMANS (PXD083999) ↗AFDSI-PROJREF-1047
Quantitative proteomic analysis of ribosome-associated proteins following human-like stressors in Cryptococcus neoformans (PXD082145) ↗AFDSI-PROJREF-1048
Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans (PXD076200) ↗AFDSI-PROJREF-1049
Classical virulence factors do not define Cryptococcus pathogenic diversity (PXD065863) ↗AFDSI-PROJREF-1050
ChEMBL rows are compounds active against a protein target from this organism — not confirmed as compounds the species itself produces, unlike ANPDB's.
ChEMBL: CHEMBL54768 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC80 0.82 ug ml-1AFDSI-METABOLOMICS-1531
ChEMBL: CHEMBL353397 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1533
ChEMBL: CHEMBL54768 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC80 0.82 ug ml-1AFDSI-METABOLOMICS-1530
ChEMBL: CHEMBL353397 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1532
ChEMBL: CHEMBL384185 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1AFDSI-METABOLOMICS-1534
ChEMBL: CHEMBL439463 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1AFDSI-METABOLOMICS-1536
ChEMBL: CHEMBL367642 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1538
ChEMBL: CHEMBL433536 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1540
ChEMBL: CHEMBL2371621 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1
MetaboLights: Bacterial profiles analysed by REIMS using Xevo G2-XS (View at source ↗)AFDSI-METABPROF-233
245 real GBIF-recorded occurrences across Africa — see this species on GBIF ↗.
This reflects real occurrence records submitted to GBIF, not a comprehensive range map — sampling effort varies significantly by country and region, so an absence here doesn't mean the species isn't present.
Genomes are often recorded at strain level. These entries belong to this species.
A node's own derived bioinformatics-analysis output (e.g. an SSR/microsatellite discovery archive) run against this species' own genome data — see the Derived Analysis page for the full catalog.
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-6170
File: GCA_056622355.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-18092MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-6171
File: GCA_010233705.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-15948ChEMBL: CHEMBL434298 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1543
ChEMBL: CHEMBL352780 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1545
ChEMBL: L-ADRENALINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 32.8 uMAFDSI-METABOLOMICS-1549
ChEMBL: CHEMBL209790 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 44.9 uMAFDSI-METABOLOMICS-1550
ChEMBL: CHEMBL32813 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 46.3 uMAFDSI-METABOLOMICS-1553
ChEMBL: CHEMBL32189 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 47.0 uMAFDSI-METABOLOMICS-1555
ChEMBL: CHEMBL384185 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1AFDSI-METABOLOMICS-1535
ChEMBL: CHEMBL439463 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1AFDSI-METABOLOMICS-1537
ChEMBL: CHEMBL367642 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1539
ChEMBL: CHEMBL2371621 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 0.01 ug.mL-1AFDSI-METABOLOMICS-1542
ChEMBL: CHEMBL434298 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1544
ChEMBL: CHEMBL352780 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 100.0 ug ml-1AFDSI-METABOLOMICS-1546
ChEMBL: L-ADRENALINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 32.8 uMAFDSI-METABOLOMICS-1547
ChEMBL: CHEMBL214205 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 40.1 uMAFDSI-METABOLOMICS-1548
ChEMBL: CHEMBL209790 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 44.9 uMAFDSI-METABOLOMICS-1551
ChEMBL: CHEMBL32813 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 46.3 uMAFDSI-METABOLOMICS-1552
ChEMBL: CHEMBL32189 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 47.0 uMAFDSI-METABOLOMICS-1554
ChEMBL: SEROTONIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 46.7 uMAFDSI-METABOLOMICS-1557
ChEMBL: SEROTONIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 46.7 uMAFDSI-METABOLOMICS-1556
ChEMBL: DOPAMINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 34.6 uMAFDSI-METABOLOMICS-1558
ChEMBL: HISTAMINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 33.2 uMAFDSI-METABOLOMICS-1560
ChEMBL: CHEMBL231389 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 30.4 uMAFDSI-METABOLOMICS-1562
ChEMBL: TYROSINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 29.5 uMAFDSI-METABOLOMICS-1564
ChEMBL: CHEMBL202870 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 25000.0 nMAFDSI-METABOLOMICS-1566
ChEMBL: CHEMBL202868 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1567
ChEMBL: CHEMBL201539 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1568
ChEMBL: CHEMBL381324 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1570
ChEMBL: CHEMBL149661 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1572
ChEMBL: CHEMBL203361 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1574
ChEMBL: CHEMBL199345 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 7500.0 nMAFDSI-METABOLOMICS-1576
ChEMBL: CHEMBL199803 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 7500.0 nMAFDSI-METABOLOMICS-1578
ChEMBL: CHEMBL199718 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3500.0 nMAFDSI-METABOLOMICS-1579
ChEMBL: DOPAMINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 34.6 uMAFDSI-METABOLOMICS-1559
ChEMBL: HISTAMINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 33.2 uMAFDSI-METABOLOMICS-1561
ChEMBL: CHEMBL231389 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 30.4 uMAFDSI-METABOLOMICS-1563
ChEMBL: TYROSINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; KA 29.5 uMAFDSI-METABOLOMICS-1565
ChEMBL: CHEMBL202870 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 25000.0 nMAFDSI-METABOLOMICS-1569
ChEMBL: CHEMBL381324 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1571
ChEMBL: CHEMBL149661 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1573
ChEMBL: CHEMBL203361 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 250000.0 nMAFDSI-METABOLOMICS-1575
ChEMBL: CHEMBL199345 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 7500.0 nMAFDSI-METABOLOMICS-1577
ChEMBL: CHEMBL199803 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 7500.0 nMAFDSI-METABOLOMICS-1580
ChEMBL: CHEMBL381029 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10000.0 nMAFDSI-METABOLOMICS-1581
ChEMBL: CHEMBL381029 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10000.0 nMAFDSI-METABOLOMICS-1582
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-5942
File: GCA_010065285.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-15947